Transdermal therapeutic system for administering the active...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/70 (2006.01) A61K 31/485 (2006.01)

Patent

CA 2670290

The invention relates to a transdermal therapeutic system for administering the active substance buprenorphine. Said system comprises at least one carboxylic acid that determines the solubility of buprenorphine in the matrix layer and that can likewise be absorbed. The transdermal therapeutic system according to the invention is used in the treatment of pain and is characterized by a considerably increased utilization of the active substance.

L'invention concerne un système thérapeutique transdermique destiné à l'administration de l'agent actif buprénorphine et comportant au moins un acide carboxylique qui détermine la solubilité de la buprénorphine dans la couche matricielle et qui est également résorbable, ce système étant destiné à une thérapie de la douleur à valorisation sensiblement accrue de l'agent actif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transdermal therapeutic system for administering the active... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal therapeutic system for administering the active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal therapeutic system for administering the active... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1490530

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.